MiraBiologics ^None

MiraBiologics is a bioventure company that aims to extend the boundaries of biopharmaceuticals by developing next-generation multifunctional biopharmaceuticals using LassoGraft Technology as a core technology. They focus on solving unmet medical needs, satisfying treatment methods in the field of rare diseases, and proposing solutions to expensive medical problems. The company originated from the University of Tokyo and Osaka University and aims to grow as a global company while contributing to human health care.